The VA/DoD Clinical Practice Guidelines updated in 2015 addresse many of the critical decision points in the management of substance use disorders among adults. The guidelines incorporate findings from a systematic review of empirical literature and other decision domains by the guideline's development panel to support actionable recommendations that can inform shared decision making by patients and providers to promote individualized care. This webinar involves an overview of the guidelines recommendations and how they were developed, including discussion of some of the gaps in the evidence base and selected clinical challenges.
Learning Objective 1
Describe at least four of the clinically important topics that provide a context for SUD care delivery that are not covered in the systematic review or by the evidence-based recommendations
Learning Objective 2
Identify at least one clinical decision about psychosocial treatment and one about pharmacotherapy for which the guideline development panel found insufficient evidence to recommend for or against a treatment approach
Learning Objective 3
Explain advantages and challenges of measurement based care for individualizing treatment and promoting improved outcomes
Presenter: Daniel R. Kivlahan, PhD
Dr. Kivlahan is currently Associate Professor, Department of Psychiatry and Behavioral Sciences, University of Washington. From 1998-2010, he was Director of the Center of Excellence in Substance Abuse Treatment and Education at VA Puget Sound in Seattle where he was an addiction treatment clinician and investigator from 1985-2010. In 2010, Dr. Kivlahan was appointed as Associate National Mental Health Program Director for Addictive Disorders, Veterans Health Administration (VHA) and he served as Director from 2012 until his retirement from VHA in 2015. He co-chaired the work groups that in 2009 and 2015 revised the VA/DoD Clinical Practice Guideline for SUD and has been active in development and validation of quality indicators based on guideline recommendations. Among his over 150 peer reviewed publications are validation studies on the AUDIT-C to screen for alcohol misuse across care settings, reports on SUD and co-occurring conditions including PTSD, and analyses from several clinical trials including the COMBINE Study for combined pharmacotherapy and psychosocial treatment of alcohol dependence.
Course Director: Bruce Liese, PhD
Bruce S. Liese, PhD, ABPP is Professor of Family Medicine and Psychiatry at the University of Kansas Medical Center, Courtesy Professor of Clinical Psychology at the University of Kansas, and current President-Elect of the Society of Addiction Psychology (SoAP; APA Division 50). Dr. Liese earned his PhD from The University at Albany in 1983. He is a teacher, clinical supervisor, researcher, and clinician. His work focuses primarily on the diagnosis and treatment of addictive behaviors. He has been Director of CBT training for a large multi-center NIDA-funded addictions study and over time has supervised hundreds of CB therapists. Presently he teaches courses on addictive behaviors, psychotherapy, and evidence-based practice in psychology and he supervises more than a dozen psychotherapy trainees. Dr. Liese has more than 50 publications, and he has co-authored two texts on addictions. He was Editor of The Addictions Newsletter for ten years, an official publication of APA Division 50. For his work on this newsletter, Dr. Liese received a President’s Citation from Division 50. He has been chosen to be a member of APA’s Continuing Education Committee, and in 2015 he received the Distinguished Career Contributions to Education and Training award from APA Division 50.
- A Consumer Checklist for Checking Out Rehabs
- Changing the Language of Addiction (JAMA)
- Bringing Patient-Centered Care to Patients with AUD (JAMA)
- A Tipping Point for Measurement-Based Care (PsychServices)
- CPG development in APA
- Key References for SUD
- Sacred Cows Greener Pastures Reflections 40 Years of Addiction Research
- Recommendations for the Design and Analysis of Treatment Trials for AUD (ACER)
- Reporting of Treatment Trials for AUD (ACER)